NSE › Healthcare

Abbott India Limited (ABBOTINDIA)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹25,910.00-0.82%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

₹1,814 cr

Revenue YoY

+4.3%

Net profit

₹429 cr

Profit YoY

+17.1%

EPS

₹201.66

EPS estimate

₹203.65

Net margin

23.6%

EPS came in at 201.66 against a street estimate of 203.65 — a miss of 1.0%.

Key statistics

Market cap

₹55,514 cr

P/E

34.4

Forward P/E

25.6

P/B

11.37

Book value

₹2,246.75

EPS (TTM)

₹758.84

52-week high

₹30,638.06

52-week low

₹24,574.94

50-day MA

₹27,059.90

200-day MA

₹26,902.62

Beta

0.04

Analyst view

with an average price target of ₹32,206.12.

Shareholding

Promoters

75.54%

Institutions

7.60%

Corporate actions

Action	Detail	Date
Dividend	₹525 / share ex-date Jul 24, 2026	2026-07-24

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Abbott India Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Lenskart Solutions Ltd Zydus Lifesciences Limited Cipla Limited Laurus Labs Limited Max Healthcare Institute Limited Aurobindo Pharma Limited Lupin Limited Dr. Reddy's Laboratories Limited

Data updated 2026-09-18.